Biochemistry is a field of enormous fascination and utility, arising, no doubt, from our own self-interest. Human welfare, particularly its medical and nutritional aspects, has been vastly improved by our rapidly growing understanding of biochemistry. Indeed, scarcely a day passes without the report of a biomedical discovery that benefits a significant portion of humanity. Further advances in this rapidly expanding field of knowledge will no doubt lead to even more spectacular gains in our ability to understand nature and to control our destinies. It is therefore essential that individuals embarking on a career in biomedical sciences be well versed in biochemistry.
Custom Search
Thursday, August 2, 2012
Biochemistry - Donald Voet, Judith G. Voet - 4th Edition
Biochemistry is a field of enormous fascination and utility, arising, no doubt, from our own self-interest. Human welfare, particularly its medical and nutritional aspects, has been vastly improved by our rapidly growing understanding of biochemistry. Indeed, scarcely a day passes without the report of a biomedical discovery that benefits a significant portion of humanity. Further advances in this rapidly expanding field of knowledge will no doubt lead to even more spectacular gains in our ability to understand nature and to control our destinies. It is therefore essential that individuals embarking on a career in biomedical sciences be well versed in biochemistry.
Friday, July 13, 2012
7 Tips for Optimal DNA Transfection
- Adapt the transfection conditions to your experiment. Transfection conditions should be optimized according to the cells, the size of the plasmid, the number of plasmids, the expression pattern of the gene of interest, the culture vessel, and the transfection reagent. Reoptimize the conditions for each new cell line.
- Transfect healthy cells. Passage cells at least twice after thawing to allow recovery before transfection, and use cells at low passage number (< 20 passages). Discard overconfluent cells. Regularly check for mycoplasma contaminations. Seed cells the day before transfection accordingly to the confluency recommended by the transfection reagent provider.
- Follow the transfection reagent protocol. Some reagents are inhibited by serum or antibiotics, while others may be used in serum- and antibiotic-containing medium, hence reducing the risks of toxicity and the number of steps in the protocol. Check the recommended cell confluency, as well as the recommended DNA amount and reagent volume.
- Work with high-quality DNA preparation. Check for RNA contamination by agarose gel electrophoresis and ethidium bromide staining. Measure UV absorbance at 280 nm. OD260/280 ratio should reach at least 1.8. Resuspend the plasmid in deionized water or TE buffer at a concentration of ca. 1 µg/µl. Aliquot the plasmid preparation and store at -20°C to avoid freeze/thaw cycles.
- Check serum quality. Some serum lots may inhibit drastically transfection efficiency, hence resulting in lower silencing efficiency. Check transfection efficiency of different serum lots before purchasing a new batch of serum. Also ensure that the medium used allows for efficient transfection, as some media coumpound may decrease transfection efficiency.
- Minimize cytotoxicity by using low DNA amount and low transfection reagent volume. Check that the target gene does not affect cell viability. Analyze transfection at an earlier time point (24 h after transfection instead of 48 h for instance).
- Use appropriate controls. Use a reporter gene to set up and optimize transfection conditions, as those may vary depending on the cells to transfect. Various reporter systems are commercially available: Renilla Luciferase and GFP (Green Fluorescent Protein) are the most commonly used.
DNA transfection
is a main tool for current genetics as well as cell and molecular
biology studies. Understanding the underlying mechanisms and the
different parameters affecting transfection is crucial for optimal,
reproducible, and trustable results. Following these seven tips will
ensure reliable results.
Thursday, July 5, 2012
Wednesday, July 4, 2012
Tuesday, July 3, 2012
Desmoid tumor: benign but nasty
Desmoid tumor, also
called deep-seated fibromatosis, is a benign tumor that is nonetheless a nasty
beast. It is composed of fibroblasts, and it often presents as a large, infiltrative
masses. Desmoid tumors may occur in patients with familial adenomatous
polyposis (also called Gardner syndrome), an autosomal dominant disorder
characterized by innumerable colon polyps (hence the name), as well as other
lesions such as osteomas, jaw osteomas, odontomas, thyroid carcinoma,
epidermoid cysts, fibromas, and sebaceous cysts. If the colon is not removed in
a patient with familial adenomatous polyposis, the chance of colon carcinoma is
virtually 100%.
Back to desmoid
tumors. These tumors usually present as firm, rubbery, ill-defined,
infiltrative masses. They may occur in extra-abdominal regions (for example, in
the shoulder or thigh), within the abdominal wall itself (often attached to the
rectus abdominus), or in the intra-abdominal region. Histologically, desmoid
tumors are composed of bland-appearing fibroblasts in broad fascicles that
infiltrate surrounding tissue. Check out the photo above: you can see muscle
fibers being splayed apart by benign-looking, round-to-spindly tumor cells.
Although benign,
desmoid tumors can act nasty. They are locally aggressive and invasive, and if
you don't excise them completely, they are likely to recur. Treatment with
things that you normally only use for malignancies, such as tamoxifen,
chemotherapy and radiation, has been effective in many cases.
Tuesday, June 12, 2012
Mastocytosis
Mastocytosis is actually a spectrum of rare disorders,
all of which are characterized by - not surprisingly - an increase in mast
cells. Most patients have disease that is localized to the skin, but about
10% of patients have systemic involvement. There is a localized, cutaneous form
of mastocytosis called urticaria pigmentosum that happens mostly in children
and accounts for over half of all cases of mastocytosis.
Clinically, the skin lesions of
mastocytosis vary in appearance. In urticaria pigmentosum, the lesions are
small, round, red-brown plaques and papules. Other cases of mastocytosis show
solitary pink-tan nodules that may be itchy or show blister formation. The
itchiness is due to the release of mast cell granules (which contain histamine
and other vasoactive substances).
In systemic mastocytosis, patients have
skin lesions similar to those of urticaria pigmentosum - but there is also mast
cell infiltration of the bone marrow, lymph nodes, spleen and liver. Patients
often suffer itchiness and flushing triggered by certain foods, temperature
changes, alcohol and certain drugs (like aspirin).
Histologically, mast cell infiltration
may be subtle (with ocasional spindle-shaped mast cells around vessels in the
superficial dermis) to dramatic (with tightly-packed mast cells in the upper to
mid-dermis - check out the photo above). Mast cells may be difficult to
distinguish in regular H&E sections; you may need a metachromatic stain
(toluidine blue or Giemsa) to really visualize the granules.
Subscribe to:
Posts (Atom)



